Skip to main content
. 2021 Oct 26;113(12):1670–1682. doi: 10.1093/jnci/djab192

Table 1.

Number of cancer patients aged 65 years and older, with Medicare Fee-for-Service Part A and Part B, SEER-Medicare 2007-2013a

Cancer site Phase of care
Initial Continuing End-of-life
Cancer Other cause
Bladder 52 490 74 913 15 180 19 633
Brain 2882 2490 7845 1705
Breast 126 034 250 192 22 527 35 908
Cervix uteri 2238 4224 1618 743
Colorectal 81 226 137 618 42 023 34 596
Esophagus 5275 5125 8449 1689
Hodgkin lymphoma 1450 2529 854 563
Kidney 26 754 40 003 10 817 8160
Leukemia 18 366 24 824 15 128 7389
 AML 2226 1804 7416 1041
 CLL 11 763 17 513 3805 4344
 CML 2598 3181 1519 1225
Liver 5644 4968 9280 2295
Lung 73 836 70 089 124 277 24 747
 NSCLC 68 128 66 400 106 775 23 007
 SCLC 5708 3689 17 502 1740
Melanoma 64 428 97 579 7212 15 635
Myeloma 11 734 13 944 9650 3733
Non-Hodgkin lymphoma 34 448 52 908 18 048 11 367
Oral cavity or pharynx 15 858 23 432 8261 5277
Ovary 8088 11 807 10 241 1492
Pancreas 8804 5321 29 571 2458
Prostate 158 840 335 539 23 403 48 559
Stomach 9411 10 623 11 809 3333
Thyroid 10 684 19 255 1688 1714
Uterus 22 098 42 161 7561 5804
All sites combined 808 148 1 316 976 436 986 270 816
a

Includes patients diagnosed with in-situ and invasive cancers. AML = acute myeloid leukemia; CLL = chronic lymphocytic leukemia; CML = chronic myeloid leukemia; NSCLC = non-small cell lung cancer; SCLC = small cell lung cancer; SEER = Surveillance, Epidemiology, and End Results Program. The reference source for this table is Mariotto et al., 2020 (4).